Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020)

Tarsus Pharmaceuticals (TARS) recorded quarterly Other Accumulated Expenses of $447000.0 in Q3 2020.

Tarsus Pharmaceuticals (TARS) Other Accumulated Expenses (2020) Analysis & Trends

Tarsus Pharmaceuticals' Other Accumulated Expenses history runs 1 years deep, the most recent figure standing at $447000.0 for Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Tarsus Pharmaceuticals	2.71 Bn	2.61 Bn	152.66 Mn

Download Data

Date	Value
Sep 30, 2020	447,000.00